Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral cisplatin as adjunct to brachytherapy in endobronchial tumors
NCT00379665Phase 2Completed
- Sponsor
- City of Hope Tulsa
- Start
- Oct 2005
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in non-small cell lung cancer (NSCLC), sponsored by City of Hope Tulsa. Started Oct 2005; status: completed.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00379665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379665.